These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8545622)

  • 41. Is this a reflux patient or is it a patient with functional dyspepsia with additional reflux symptoms?
    Funch-Jensen P
    Scand J Gastroenterol Suppl; 1995; 211():29-31. PubMed ID: 8545627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Interpretation and role of endoscopy in gastroesophageal reflux].
    Devière J
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S17-20. PubMed ID: 10078427
    [No Abstract]   [Full Text] [Related]  

  • 43. [Reflux esophagitis, endoscopic and biopsy findings].
    Ottenjann R; Gruner HJ; Strauch M
    Leber Magen Darm; 1972 Feb; 2(2):48-52. PubMed ID: 5073411
    [No Abstract]   [Full Text] [Related]  

  • 44. Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia.
    Irvine AJ; Pinto-Sanchez MI; Bercik P; Moayyedi P; Ford AC
    Scand J Gastroenterol; 2017 Apr; 52(4):396-402. PubMed ID: 27973922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of oesophageal reflux disease.
    Heading RC
    Scand J Gastroenterol Suppl; 1989; 168():33-7. PubMed ID: 2617176
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Symptoms and endoscopic findings--can they predict abnormal nocturnal acid gastro-oesophageal reflux?
    Jenkinson LR; Norris TL; Watson A
    Ann R Coll Surg Engl; 1989 Mar; 71(2):117-9. PubMed ID: 2650603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non-erosive reflux disease.
    Kusano M; Hosaka H; Kawada A; Kuribayashi S; Shimoyama Y; Kawamura O; Moki F
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1187-91. PubMed ID: 22414314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
    Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. There is no correlation between signs of reflux laryngitis and reflux oesophagitis in patients with gastro-oesophageal reflux disease symptoms.
    Zelenik K; Kajzrlikova IM; Vitek P; Urban O; Hanousek M; Kominek P
    Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):401-405. PubMed ID: 29165435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastroesophageal reflux disease: clinical features.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):417-20. PubMed ID: 16341946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
    Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
    Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Problems of gastroesophageal reflux in childhood].
    Höllwarth ME; Uray E; Pesendorfer P; Sauer H
    Wien Med Wochenschr; 1986 May; 136(10):227-31. PubMed ID: 3751067
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.
    Ando T; El-Omar EM; Goto Y; Nobata K; Watanabe O; Maeda O; Ishiguro K; Minami M; Hamajima N; Goto H
    Gut; 2006 Feb; 55(2):158-64. PubMed ID: 16120761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Gastro-esophageal reflux: is there a correlation between the degree of reflux and its effects?].
    Weiser HF; Hölscher A; Siewert JR
    Dtsch Med Wochenschr; 1983 Jun; 108(24):930-5. PubMed ID: 6851889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Heartburn without esophagitis. Symptoms more important than the finding?].
    Füessl HS
    MMW Fortschr Med; 2003 Sep; 145(39):4-6. PubMed ID: 14649061
    [No Abstract]   [Full Text] [Related]  

  • 58. [The lacto-complex in the therapy of gastroesophageal reflux. Clinical and endoscopic evaluation].
    Rossini FP; Ferrari A
    Minerva Med; 1975 Apr; 66(25):1204-12. PubMed ID: 1134661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
    Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
    Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Topic complex III: Therapy of non-erosive reflux disease (NERD)].
    Koop H; Classen M; Liebe S; Lütke A; Wienbeck M
    Z Gastroenterol; 2005 Feb; 43(2):176-9. PubMed ID: 15700209
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.